Clinical Trial Update: Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the combination of stiripentol and carbamazepine for pharmacoresistant focal epilepsies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Focal Epilepsy

Drugs mentioned

• Carbamazepine (Carbamazepine)
• Diacomit (stiripentol)

Snippet

Sponsor: Biocodex | Conditions: Pharmacoresistant Focal Epilepsies | Phase 4 | Status: COMPLETED